Patents by Inventor Claude A. Piche

Claude A. Piche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nasal powder formulation for treatment of hypoglycemia
    Patent number: 12370241
    Abstract: The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.
    Type: Grant
    Filed: February 10, 2023
    Date of Patent: July 29, 2025
    Assignee: Amphastar Pharmaceuticals, Inc.
    Inventors: Sankaram Mantripragada, Claude A. Piche, Jo Jan Filip Van Betsbrugge
  • Nasal powder formulation for treatment of hypoglycemia
    Patent number: 12226456
    Abstract: The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: February 18, 2025
    Assignee: Amphastar Pharmaceuticals, Inc.
    Inventors: Sankaram Mantripragada, Claude A. Piche, Jo Jan Filip Van Betsbrugge
  • NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA
    Publication number: 20190282666
    Abstract: The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.
    Type: Application
    Filed: February 4, 2019
    Publication date: September 19, 2019
    Inventors: Sankaram Mantripragada, Claude A. Piche, Jo Jan Filip Van Betsbrugge
  • Nasal powder formulation for treatment of hypoglycemia
    Patent number: 10213487
    Abstract: The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: February 26, 2019
    Assignee: Eli Lilly and Company
    Inventors: Sankaram Mantripragada, Claude A. Piche, Jo Jan Filip Van Betsbrugge
  • NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA
    Publication number: 20180000904
    Abstract: The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.
    Type: Application
    Filed: February 16, 2016
    Publication date: January 4, 2018
    Inventors: Sankaram Mantripragada, Claude A. Piche, Jo Jan Filip Van Betsbrugge